Chakrani, Z., Patel, M., Mellgard, G., McCroskery, S., Saffran, N., Taylor, N., Liaw, B. C., Galsky, M., Oh, W., Tsao, C.-K., Ganta, T., & Patel, V. (2024). The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Clinical Genitourinary Cancer, 22(6), 102227. https://doi.org/10.1016/j.clgc.2024.102227

Lim, E. A., Schweizer, M. T., Chi, K. N., Aggarwal, R., Agarwal, N., Gulley, J., Attiyeh, E., Greger, J., Wu, S., Jaiprasart, P., Loffredo, J., Bandyopadhyay, N., Xie, H., & Hansen, A. R. (2023). Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer, 21(3), 366–375. https://doi.org/10.1016/j.clgc.2023.02.010

Anderson, C. B., Chen, L., Chang, S. S., McKiernan, J. M., & Wright, J. (2022). Intravesical Therapy Compared to Radical Cystectomy Among Patients With Non-Muscle Invasive Bladder Cancer Requiring Additional Treatment After Induction BCG. Clinical Genitourinary Cancer, 20(6), 595–603. https://doi.org/10.1016/j.clgc.2022.07.001